Late-stage clinical development of Chikungunya vaccines in endemic countries (CHIKV) and Controlled Human Infection Models for SARS-CoV2 and other beta coronaviruses (CHIM).

Project Information

CHIKVAX_CHIM

Grant agreement ID: 101126531

DOI 10.3030/101126531

EC signature date 15 June 2023

Start date 1 June 2023

End date 30 November 2028

Funded under

• Health

Total cost € 100 000 000,00

EU contribution € 70 000 000,00

Coordinated by

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Norway

Deliverables

Websites, patent fillings, videos etc. (2)

CHIM CfP publication on CEPI website

Publication on CEPI website of the CHIM Call for Proposals due on month 3

CHIK Vaccine CfP publication on CEPI website

Publication of the CHIK Vaccine call for proposals CfP on CEPIs website